Accessibility Tools
Depression Is Notoriously Difficult to Treat. Can Psychedelic Therapies Help?

A highly heterogeneous disease, depression has long challenged drug developers. While effective treatments exist for some patients, many are still left behind by current regimens. Now, with the global depression treatment market projected to top $16 billion by 2027, psychedelic drug developers have their sights set on the space, with six programs currently in clinical development, according to Psychedelic Alpha.

Know More


Sign Up for the Fermata Mailing List!

  • *
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.

Location & Directions


58 N 9th St #103,
Brooklyn, NY 11249

Mon To Fri 9.00 am to 7.00 pm

Technology Partners